PLoS ONE · 2011 · 23 citations · 29 references
Life SciencesImmunologyInfectious DiseasesInnate ImmunityVaccinologyVirologyAntiviral ImmunityVaccinationVaccine DeliveryViral InfectionsViral VaccinesViral Vector VaccinesAdenoviral Vaccine VectorsAdenovirus VaccinesAdenovirus VectorsHost Defense ResponsesInfluenza Antiviral TherapyInfluenza TreatmentInnate Immunity PathwaysMechanisms Of Vaccine-induced Protection
Few other diseases exert such a huge toll of suffering as influenza. We report here that intranasal (i.n.) administration of E1/E3-defective (ΔE1E3) adenovirus serotype 5 (Ad5) particles rapidly induced an anti-influenza state as a means of prophylactic therapy which persisted for several weeks in mice. By encoding an influenza virus (IFV) hemagglutinin (HA) HA1 domain, an Ad5-HA1 vector conferred rapid protection as a prophylactic drug followed by elicitation of sustained protective immunity as a vaccine for inducing seamless protection against influenza as a drug-vaccine duo (DVD) in a single package. Since Ad5 particles induce a complex web of host responses, which could arrest influenza by activating a specific arm of innate immunity to impede IFV growth in the airway, it is conceivable that this multi-pronged influenza DVD may escape the fate of drug resistance that impairs the current influenza drugs.
29
Human host factors required for influenza virus replication
Renate König, Silke Stertz, Yingyao Zhou et al. · Nature · 2009 · 821 citations · Full text
Jun Wang, Lisa Thorson, Richard W. Stokes et al. · The Journal of Immunology · 2004 · 361 citations · Full text
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Chih‐Jen Wei, Jeffrey C. Boyington, Patrick M. McTamney et al. · Science · 2010 · 341 citations